{"id":"https://openalex.org/W7166643772","doi":"https://doi.org/10.1016/j.jtocrr.2026.101037","title":"Garsorasib (D-1553) in Combination With Pembrolizumab and Chemotherapy for First-Line Metastatic NSCLC With KRAS G12C Mutation: Results of a Phase 1b Study","display_name":"Garsorasib (D-1553) in Combination With Pembrolizumab and Chemotherapy for First-Line Metastatic NSCLC With KRAS G12C Mutation: Results of a Phase 1b Study","publication_year":2026,"publication_date":"2026-06-30","ids":{"openalex":"https://openalex.org/W7166643772","doi":"https://doi.org/10.1016/j.jtocrr.2026.101037","pmid":"https://pubmed.ncbi.nlm.nih.gov/42924167","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13689614"},"language":"en","primary_location":{"id":"doi:10.1016/j.jtocrr.2026.101037","doi":"https://doi.org/10.1016/j.jtocrr.2026.101037","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jtocrr.2026.101037","pdf_url":"https://www.jtocrr.org/article/S2666-3643(26)00088-3/pdf","source":{"id":"https://openalex.org/S4210220242","display_name":"JTO Clinical and Research Reports","issn_l":"2666-3643","issn":["2666-3643"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","norway-1","poland-20"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JTO Clinical and Research Reports","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.jtocrr.org/article/S2666-3643(26)00088-3/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042265572","display_name":"Dong Yan","orcid":"https://orcid.org/0000-0003-2483-4029","observed_orcids":["https://orcid.org/0000-0003-2483-4029","https://orcid.org/0000-0002-7053-3078"]},"institutions":[{"id":"https://openalex.org/I183519381","display_name":"Capital Medical University","ror":"https://ror.org/013xs5b60","country_code":"CN","type":"education","lineage":["https://openalex.org/I183519381"]},{"id":"https://openalex.org/I4210114604","display_name":"Beijing Luhe Hospital Affiliated to Capital Medical University","ror":"https://ror.org/01zyn4z03","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210114604"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Dong Yan","raw_affiliation_strings":["Department of Oncology, Beijing Luhe Hospital, Capital Medical University, Beijing, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Beijing Luhe Hospital, Capital Medical University, Beijing, People's Republic of China","institution_ids":["https://openalex.org/I183519381","https://openalex.org/I4210114604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5139632573","display_name":"Chaoying Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158071","display_name":"Wuxi People's Hospital","ror":"https://ror.org/05pb5hm55","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210158071"]},{"id":"https://openalex.org/I83519826","display_name":"Nanjing Medical University","ror":"https://ror.org/059gcgy73","country_code":"CN","type":"education","lineage":["https://openalex.org/I83519826"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chaoying Liu","raw_affiliation_strings":["Department of Oncology, Wuxi People's Hospital, Nanjing Medical University, Wuxi, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Wuxi People's Hospital, Nanjing Medical University, Wuxi, People's Republic of China","institution_ids":["https://openalex.org/I4210158071","https://openalex.org/I83519826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102845102","display_name":"Xingya Li","orcid":"https://orcid.org/0000-0002-8265-7318","observed_orcids":["https://orcid.org/0000-0002-8265-7318","https://orcid.org/0009-0005-0711-5702"]},"institutions":[{"id":"https://openalex.org/I4210156804","display_name":"First Affiliated Hospital of Zhengzhou University","ror":"https://ror.org/056swr059","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210156804"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xingya Li","raw_affiliation_strings":["Department of Medical Oncology, The First Affiliated Hospital of Zhengzhou University, Henan, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, The First Affiliated Hospital of Zhengzhou University, Henan, People's Republic of China","institution_ids":["https://openalex.org/I4210156804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5128171633","display_name":"Melissa Moore","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I4210087110","display_name":"St Vincent's Hospital Melbourne","ror":"https://ror.org/001kjn539","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210087110","https://openalex.org/I4210098850"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Melissa Moore","raw_affiliation_strings":["Department of Medical Oncology, St. Vincent's Hospital, Melbourne, VIC, Australia; Department of Medicine, University of Melbourne, Melbourne, VIC, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, St. Vincent's Hospital, Melbourne, VIC, Australia; Department of Medicine, University of Melbourne, Melbourne, VIC, Australia","institution_ids":["https://openalex.org/I165779595","https://openalex.org/I4210087110"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5139651919","display_name":"Ruihua Xu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146711","display_name":"Sun Yat-sen University Cancer Center","ror":"https://ror.org/0400g8r85","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210146711"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ruihua Xu","raw_affiliation_strings":["Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China","institution_ids":["https://openalex.org/I4210146711"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005462156","display_name":"Rachel E. Sanborn","orcid":"https://orcid.org/0000-0003-0542-6054","observed_orcids":["https://orcid.org/0000-0003-0542-6054"]},"institutions":[{"id":"https://openalex.org/I2801670537","display_name":"Providence Portland Medical Center","ror":"https://ror.org/015tmw922","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801670537","https://openalex.org/I4210160466","https://openalex.org/I94396219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rachel E. Sanborn","raw_affiliation_strings":["Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon","institution_ids":["https://openalex.org/I2801670537"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025836672","display_name":"Shirish M. Gadgeel","orcid":"https://orcid.org/0000-0001-5240-3811","observed_orcids":["https://orcid.org/0000-0001-5240-3811"]},"institutions":[{"id":"https://openalex.org/I2803043754","display_name":"Henry Ford Hospital","ror":"https://ror.org/0193sb042","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I154057602","https://openalex.org/I2803043754"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shirish M. Gadgeel","raw_affiliation_strings":["Division of Hematology/Oncology, Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, Department of Internal Medicine, Henry Ford Hospital, Detroit, Michigan","institution_ids":["https://openalex.org/I2803043754"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079833339","display_name":"Michael Millward","orcid":"https://orcid.org/0000-0002-1744-1617","observed_orcids":["https://orcid.org/0000-0002-1744-1617"]},"institutions":[{"id":"https://openalex.org/I177877127","display_name":"The University of Western Australia","ror":"https://ror.org/047272k79","country_code":"AU","type":"education","lineage":["https://openalex.org/I177877127"]},{"id":"https://openalex.org/I4210156497","display_name":"Linear Clinical Research","ror":"https://ror.org/05vnpr825","country_code":"AU","type":"facility","lineage":["https://openalex.org/I4210156497"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Michael Millward","raw_affiliation_strings":["Linear Clinical Research, Ltd., and School of Medicine, University of Western Australia, Perth, West Australia, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Linear Clinical Research, Ltd., and School of Medicine, University of Western Australia, Perth, West Australia, Australia","institution_ids":["https://openalex.org/I177877127","https://openalex.org/I4210156497"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5139686429","display_name":"Zhe Shi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268094","display_name":"InventisBio Co., Ltd. (China)","ror":"https://ror.org/05s4wn714","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405268094"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhe Shi","raw_affiliation_strings":["InventisBio Co., Ltd., Shanghai, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"InventisBio Co., Ltd., Shanghai, People's Republic of China","institution_ids":["https://openalex.org/I4405268094"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002237217","display_name":"Yaolin Wang","orcid":"https://orcid.org/0000-0003-1932-9810","observed_orcids":["https://orcid.org/0000-0003-1932-9810"]},"institutions":[{"id":"https://openalex.org/I4405268094","display_name":"InventisBio Co., Ltd. (China)","ror":"https://ror.org/05s4wn714","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405268094"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yaolin Wang","raw_affiliation_strings":["InventisBio Co., Ltd., Shanghai, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"InventisBio Co., Ltd., Shanghai, People's Republic of China","institution_ids":["https://openalex.org/I4405268094"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011091151","display_name":"Kathryn Stazzone","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268094","display_name":"InventisBio Co., Ltd. (China)","ror":"https://ror.org/05s4wn714","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405268094"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Kathryn Stazzone","raw_affiliation_strings":["InventisBio Co., Ltd., Shanghai, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"InventisBio Co., Ltd., Shanghai, People's Republic of China","institution_ids":["https://openalex.org/I4405268094"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5133836062","display_name":"Michael J. Chisamore","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael J. Chisamore","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5139660918","display_name":"Ling Zhang","orcid":"https://orcid.org/0009-0001-1668-1002","observed_orcids":["https://orcid.org/0009-0001-1668-1002"]},"institutions":[{"id":"https://openalex.org/I4405268094","display_name":"InventisBio Co., Ltd. (China)","ror":"https://ror.org/05s4wn714","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405268094"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Ling Zhang","raw_affiliation_strings":["InventisBio Co., Ltd., Shanghai, People's Republic of China"],"raw_orcid":"https://orcid.org/0009-0001-1668-1002","affiliations":[{"raw_affiliation_string":"InventisBio Co., Ltd., Shanghai, People's Republic of China","institution_ids":["https://openalex.org/I4405268094"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":14,"corresponding_author_ids":["https://openalex.org/A5139660918"],"corresponding_institution_ids":["https://openalex.org/I4405268094"],"apc_list":{"value":2000,"currency":"USD","value_usd":2000},"apc_paid":{"value":2000,"currency":"USD","value_usd":2000},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.46565786,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"7","issue":"10","first_page":"101037","last_page":"101037"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kras-g12c-mutation","display_name":"KRAS G12C mutation","score":0.9670000076293945},{"id":"https://openalex.org/keywords/metastatic-nsclc","display_name":"metastatic non-small cell lung cancer","score":0.9599999785423279},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.996999979019165},{"id":"https://openalex.org/keywords/platinum-based-chemotherapy","display_name":"platinum-based chemotherapy","score":0.9300000071525574},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6079999804496765},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.7850000262260437},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8679999709129333},{"id":"https://openalex.org/keywords/treatment-related-adverse-events","display_name":"treatment-related adverse events","score":0.9580000042915344},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.43700000643730164}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8738999962806702},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.7634999752044678},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5792999863624573},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5777000188827515},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5709999799728394},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5698000192642212},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3776000142097473},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.3671000003814697},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.31839999556541443},{"id":"https://openalex.org/C3019992650","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Palliative chemotherapy","level":3,"score":0.304500013589859},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.29679998755455017},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.29319998621940613},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.2759000062942505},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.27489998936653137},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.27230000495910645},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.2630999982357025},{"id":"https://openalex.org/C3018227240","wikidata":"https://www.wikidata.org/wiki/Q2481887","display_name":"Adjuvant chemotherapy","level":4,"score":0.257999986410141}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1016/j.jtocrr.2026.101037","doi":"https://doi.org/10.1016/j.jtocrr.2026.101037","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jtocrr.2026.101037","pdf_url":"https://www.jtocrr.org/article/S2666-3643(26)00088-3/pdf","source":{"id":"https://openalex.org/S4210220242","display_name":"JTO Clinical and Research Reports","issn_l":"2666-3643","issn":["2666-3643"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","norway-1","poland-20"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JTO Clinical and Research Reports","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13689614","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13689614/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13689614/pdf/main.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JTO Clin Res Rep","raw_type":"Text"},{"id":"pmid:42924167","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42924167","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JTO clinical and research reports","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:9bc5c18cf1ce4c85a4dbe8c498da4bcc","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/9bc5c18cf1ce4c85a4dbe8c498da4bcc","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"JTO Clinical and Research Reports, Vol 7, Iss 10, Pp 101037- (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.jtocrr.2026.101037","doi":"https://doi.org/10.1016/j.jtocrr.2026.101037","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jtocrr.2026.101037","pdf_url":"https://www.jtocrr.org/article/S2666-3643(26)00088-3/pdf","source":{"id":"https://openalex.org/S4210220242","display_name":"JTO Clinical and Research Reports","issn_l":"2666-3643","issn":["2666-3643"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","norway-1","poland-20"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JTO Clinical and Research Reports","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4133416284","display_name":"MSD","ror":null},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7166643772.pdf","grobid_xml":"https://content.openalex.org/works/W7166643772.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W2037139573","https://openalex.org/W2796582438","https://openalex.org/W2892640821","https://openalex.org/W3045278119","https://openalex.org/W3093317346","https://openalex.org/W3120172300","https://openalex.org/W3172081492","https://openalex.org/W3214173072","https://openalex.org/W4220717021","https://openalex.org/W4281650778","https://openalex.org/W4282976626","https://openalex.org/W4285987606","https://openalex.org/W4289935959","https://openalex.org/W4297075058","https://openalex.org/W4308522396","https://openalex.org/W4311292692","https://openalex.org/W4328104940","https://openalex.org/W4375954625","https://openalex.org/W4387491491","https://openalex.org/W4387809560","https://openalex.org/W4388046002","https://openalex.org/W4396582616","https://openalex.org/W4399477559","https://openalex.org/W4400036521","https://openalex.org/W4402560635","https://openalex.org/W4403410372","https://openalex.org/W4410803745","https://openalex.org/W4416808481","https://openalex.org/W4416810305","https://openalex.org/W7125708506"],"related_works":["https://openalex.org/W4393989157","https://openalex.org/W4399477559","https://openalex.org/W4381434914","https://openalex.org/W4328104940","https://openalex.org/W4411331277","https://openalex.org/W4416822351","https://openalex.org/W7167621813","https://openalex.org/W4416976247","https://openalex.org/W4401513684","https://openalex.org/W7131799886"],"abstract_inverted_index":{"Background":[0],"Garsorasib":[1],"(D-1553)":[2],"is":[3],"an":[4,206],"orally":[5],"administered":[6],"selective":[7],"KRAS":[8,33,49,198],"G12C":[9,50],"inhibitor.":[10],"We":[11],"report":[12],"results":[13],"from":[14],"group":[15,166],"1":[16],"of":[17,86,107,113,140,170,209,213],"the":[18,164,181,211,241],"phase":[19,247],"1b":[20],"D1553-101":[21],"study":[22,242],"assessing":[23],"garsorasib":[24,62,120,217],"plus":[25,57,81,135,218],"pembrolizumab":[26,56,74,134,219],"and":[27,52,90,96,105,149,187,220,225],"platinum-based":[28,58,136,221],"chemotherapy":[29,222],"in":[30,163],"participants":[31,41,118,141,196,226],"with":[32,48,73,133,197,216],"G12C\u2012mutated":[34,199],"advanced":[35,44,201],"or":[36,45,68,88,94,127,155,202,231],"metastatic":[37,46,203],"NSCLC.":[38],"Methods":[39],"Eligible":[40],"had":[42,151,227],"locally":[43,200],"NSCLC":[47],"mutation":[51],"were":[53,103],"candidates":[54],"for":[55],"chemotherapy.":[59,137],"Participants":[60],"received":[61,119],"600":[63,121],"mg":[64,76,122],"once":[65,77],"daily":[66,70],"(QD)":[67],"twice":[69],"(BID)":[71],"combined":[72,132],"200":[75],"every":[78],"3":[79],"weeks":[80],"4":[82],"to":[83,158,234],"6":[84],"cycles":[85],"cisplatin":[87],"carboplatin":[89,95],"pemetrexed":[91],"(nonsquamous":[92],"histology)":[93],"paclitaxel":[97],"(squamous":[98],"histology).":[99],"The":[100],"primary":[101],"endpoints":[102],"safety":[104],"incidence":[106,212],"dose-limiting":[108],"toxicities":[109],"(DLTs).":[110],"Results":[111],"As":[112],"February":[114],"24,":[115],"2024,":[116],"17":[117],"QD":[123],"(n":[124,129],"=":[125,130],"10)":[126],"BID":[128,165],"7)":[131],"Overall,":[138],"94%":[139],"experienced":[142,167],"grade":[143,171],"\u22653":[144],"treatment-related":[145,159,214,235],"adverse":[146],"events":[147],"(AEs)":[148],"88%":[150],"a":[152,168],"dose":[153,229],"reduction":[154],"interruption":[156,232],"due":[157,233],"AEs.":[160,236],"One":[161],"participant":[162],"DLT":[169],"2":[172],"diarrhea;":[173],"no":[174],"other":[175],"DLTs":[176],"occurred.":[177],"Among":[178],"all":[179],"participants,":[180],"objective":[182],"response":[183],"rate":[184],"was":[185,191,223],"59%":[186],"median":[188],"progression-free":[189],"survival":[190],"7.4":[192],"months.":[193],"Conclusion":[194],"In":[195],"NSCLC,":[204],"despite":[205],"encouraging":[207],"signal":[208],"efficacy,":[210],"AEs":[215],"high,":[224],"frequent":[228],"modification":[230],"Based":[237],"on":[238],"these":[239],"findings,":[240],"did":[243],"not":[244],"proceed":[245],"into":[246],"2.":[248],"(NCT04585035)":[249]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-07-01T00:00:00"}